HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Parkinson disease protein α-synuclein inhibits autophagy.

Abstract
Parkinson disease (PD) is the most common movement disorder affecting people. It is characterized by the accumulation of the protein α-synuclein in Lewy body inclusions in vulnerable neurons. α-Synuclein overexpression caused by gene multiplications is sufficient to cause this disease, suggesting that α-synuclein accumulation is toxic. Here we review our recent study showing that α-synuclein inhibits autophagy. We discuss our mechanistic understanding of this phenomenon and also speculate how a deficiency in autophagy may contribute to a range of pleiotropic features of PD biology.
AuthorsAshley R Winslow, David C Rubinsztein
JournalAutophagy (Autophagy) Vol. 7 Issue 4 Pg. 429-31 (Apr 2011) ISSN: 1554-8635 [Electronic] United States
PMID21157184 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • ATG9B protein, human
  • Autophagy-Related Proteins
  • Membrane Proteins
  • alpha-Synuclein
  • rab1 GTP-Binding Proteins
Topics
  • Animals
  • Autophagy
  • Autophagy-Related Proteins
  • Gene Expression Regulation
  • Golgi Apparatus (metabolism)
  • Humans
  • Lewy Bodies (metabolism)
  • Membrane Proteins (metabolism)
  • Mitochondria (metabolism)
  • Models, Biological
  • Parkinson Disease (metabolism)
  • Phagosomes (metabolism)
  • alpha-Synuclein (metabolism)
  • rab1 GTP-Binding Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: